ACI’s 13th Annual Summit for Women Leaders in Life Sciences Law

The American Conference Institute’s (“ACI”) 13th Annual Summit for Women Leaders in Life Sciences Law returns July 29-30, 2026, at the Seaport Hotel Boston in Boston, Massachusetts.

ACI’s Summit for Women Leaders in Life Sciences Law is dedicated to providing the invaluable opportunities for networking and collaboration with the chance to meet, engage with, and learn from over 350 attorneys and executives from the biotech, pharmaceutical, and medical device industries and keep you up-to-date on the latest developments and challenges in the industry.

This year’s summit is bigger than ever, featuring:

• A Fireside Chat with FDA and EMA, focused on key agency initiatives and leadership in the public sector
• CEO Spotlight Interviews with Arivee Vargas (CEO & Found of Humble Rising, and Former Executive Coach at Vertex Pharmaceuticals) and Lara Sullivan (Board Member, President & CEO of Pyxis Oncology)
• Discussions on Navigating MFN Drug Pricing, TrumpRX, Direct-to-Patient Models, Commercial Disruption, Tariff Turbulence, AI-use in Product Development and Workflows, and more
• Intimate Roundtable Discussions on Multigenerational Workforces, Personal Branding, Self-Advocacy, and Leadership and Retention
• A Brand-new Interactive Workshop: the Boardroom Experience – A Live Board Meeting Simulation for Aspiring Board Members, facilitated by Diana Markaki-Bartholdi (Founder of the Boardroom)

Don’t miss the event that has been connecting women leaders in life sciences law for over a decade.

Hyman, Phelps & McNamara, P.C.’s Sara W. Koblitz will be speaking at a panel session, titled “Navigating the New Landscape of Direct-to-Consumer Advertising and Influencer Marketing in the Life Sciences Industry.”

FDA Law Blog is a conference media partner. As such, we can offer our readers a special 10% discount. The discount code is: D10-999-FDA26. You can access the conference brochure and sign up for the event here.  We look forward to seeing you at the conference.